Aardvark Therapeutics, Inc. Common Stock (AARD) — Financial statements
Income statement, balance sheet, and cash flow for Aardvark Therapeutics, Inc. Common Stock — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue & Gross Profit | |||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenue | 0.04 | 0.00 | 0.00 | 0.00 | |
| Gross Profit | -0.04 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | |||||
| R&D Expenses | 49↑181.8% | 17↑287.6% | 4↓37.5% | 7 | |
| General & Administrative Expenses | 14↑159.9% | 5↑144.1% | 2↓19.6% | 3 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 14↑159.9% | 5↑144.1% | 2↓19.6% | 3 | |
| Other Expenses | 0.00↓100.0% | 0.12↓84.6% | 0.76↓48.8% | 1 | |
| Operating Expenses | 63↑175.3% | 23↑207.3% | 7↓34.7% | 11 | |
| Total Costs & Expenses | 63↑175.3% | 23↑207.3% | 7↓34.7% | 11 | |
| Operating Results | |||||
| Operating Income | -63↓175.3% | -23↓207.3% | -7↑34.7% | -11 | |
| Depreciation & Amortization | 0.00↓100.0% | 0.02 | 0.00↓100.0% | 0.11 | |
| EBITDA | -63↓176.9% | -23↓240.5% | -7↑31.9% | -10 | |
| EBIT | -63↓176.7% | -23↓240.7% | -7↑32.6% | -10 | |
| Interest & Other Income | |||||
| Net Interest Income | 5↑112.9% | 2↑69.6% | 1↑1085.8% | 0.12 | |
| Interest Income | 5↑112.9% | 2↑69.6% | 1↑1085.8% | 0.12 | |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | |
| Non-Operating Income | 0.00↑100.0% | -0.12↑84.6% | -0.76↑48.8% | -1 | |
| Other Income / Expenses | 5↑133.7% | 2↑961.4% | 0.21↑109.4% | -2 | |
| Income Before Tax | -58↓179.7% | -21↓185.6% | -7↑46.9% | -14 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | |||||
| Net Income from Continuing Operations | -58↓179.7% | -21↓185.6% | -7↑46.9% | -14 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -58↓179.7% | -21↓185.6% | -7↑46.9% | -14 | |
| Bottom-Line Net Income | -58↓179.7% | -21↓185.6% | -7↑46.9% | -14 | |
| EPS (Basic) | -2.64↓177.9% | -0.95↓179.4% | -0.34↑46.0% | -0.63 | |
| EPS (Diluted) | -2.64↓177.9% | -0.95↓179.4% | -0.34↑46.0% | -0.63 | |
| Weighted Average Shares | 22↑0.6% | 22↑1.5% | 21↑0.0% | 21 | |
| Weighted Average Diluted Shares | 22↑0.6% | 22↑1.5% | 21↑0.0% | 21 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.